ELI LILLY & Co — Director's Dealing 2016

Jan 25, 2016

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2015-12-31

Reporting Person: Mahony Susan (SVP & Pres., Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-04	Common Stock	G	140	—	Disposed	62588	Direct
2015-11-06	Common Stock	G	600	—	Disposed	8384	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1637	Indirect
Common Stock	1627	Indirect

Footnotes

F1: Reporting person disclaims beneficial ownership of these shares.